eCite Digital Repository

Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L

Citation

Findlay, VL and Zilberg, D and Munday, BL, Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L, Journal of Fish Diseases, 23, (3) pp. 193-198. ISSN 0140-7775 (2000) [Refereed Article]

DOI: doi:10.1046/j.1365-2761.2000.00238.x

Abstract

Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.

Item Details

Item Type:Refereed Article
Research Division:Agricultural and Veterinary Sciences
Research Group:Fisheries Sciences
Research Field:Fish Pests and Diseases
Objective Division:Animal Production and Animal Primary Products
Objective Group:Fisheries - Aquaculture
Objective Field:Fisheries - Aquaculture not elsewhere classified
Author:Zilberg, D (Dr Dina Zilberg)
Author:Munday, BL (Dr Barry Munday)
ID Code:19014
Year Published:2000
Web of Science® Times Cited:29
Deposited By:TAFI - Aquaculture
Deposited On:2000-08-01
Last Modified:2011-11-07
Downloads:0

Repository Staff Only: item control page